Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials

Published:2023-06-12 Issue: Volume:10 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Dixit Neal M.,Amsterdam Ezra A.

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy;Velazquez;N Engl J Med,2016

2. Percutaneous revascularization for ischemic left ventricular dysfunction;Perera;N Engl J Med,2022

3. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Heidenreich;Circulation

4. The gap to fill: rationale for rapid initiation and optimal titration of comprehensive disease-modifying medical therapy for heart failure with reduced ejection fraction;Brownell;Card Fail Rev,2021

5. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry;Greene;J Am Coll Cardiol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP